UDIBI

Batch-to-batch reproducibility of Transferon™ VER MÁS

Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point...

Fecha de publicación: 6 de octubre de 2021 Increased survival in puppies affected by Canine Parvovirus type II using...

Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release....

An international comparative analysis and roadmap to sustainable biosimilar markets. VER MÁS

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS

Fecha de publicación: 28 de agosto de 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies Ver más